73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Magnetic field patterns found to cause oncolysis via oxidative stress in glioma cells

Magnetic field patterns found to cause oncolysis via oxidative stress in glioma cells

by Thamarasee Jeewandara , Medical XpressCell culture stimulation setup, stimulation protocol and thermal imaging during sOMF stimulation to measure temperature changes. (A) Left—A schematic diagram o

Magnetic field patterns found to cause oncolysis via oxidative stress in glioma cells

by Thamarasee Jeewandara , Medical XpressCell culture stimulation setup, stimulation protocol and thermal imaging during sOMF stimulation to measure temperature changes. (A) Left—A schematic diagram o
Study uncovers the role of NETO2-mediated regulation in melanoma progression

Study uncovers the role of NETO2-mediated regulation in melanoma progression

by Frontiers JournalsCredit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0935-0Cong Peng and others at the Department of Dermatology, Xiangya Hospital, Central South University, Ch

Study uncovers the role of NETO2-mediated regulation in melanoma progression

by Frontiers JournalsCredit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0935-0Cong Peng and others at the Department of Dermatology, Xiangya Hospital, Central South University, Ch
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
New compounds block master regulator of cancer growth, metastasis

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,
Finding a non-invasive way to predict effectiveness of cancer therapy

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an
Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i
Researchers test previously approved FDA drugs to treat Lowe syndrome

Researchers test previously approved FDA drugs to treat Lowe syndrome

by Purdue UniversityR. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Fo

Researchers test previously approved FDA drugs to treat Lowe syndrome

by Purdue UniversityR. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Fo
Women more prone to selected oesophagogastric cancer chemotherapy side-effects

Women more prone to selected oesophagogastric cancer chemotherapy side-effects

byEuropean Society for Medical OncologyMen and women may need to be treated differently—at least when it comes to some types of cancer. In an analysis (1) to be presented at the ESMO 2018 Congre

Women more prone to selected oesophagogastric cancer chemotherapy side-effects

byEuropean Society for Medical OncologyMen and women may need to be treated differently—at least when it comes to some types of cancer. In an analysis (1) to be presented at the ESMO 2018 Congre
New research finds oral leukemia therapy to work as well as intravenous decitabine

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival
Ultrasensitive blood test detects 'pan-cancer' biomarker

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit
Chemically 'poisoned' protein acts as a molecular switch to spur cancer formation

Chemically 'poisoned' protein acts as a molecular switch to spur cancer formation

byThe Scripps Research InstituteResearchers discovered that when the protein DNMT3B becomes S-nitrosylated in the presence of nitric oxide (NO), cancer-related genes become activated, leading to

Chemically 'poisoned' protein acts as a molecular switch to spur cancer formation

byThe Scripps Research InstituteResearchers discovered that when the protein DNMT3B becomes S-nitrosylated in the presence of nitric oxide (NO), cancer-related genes become activated, leading to
Era of hope for patients with lung cancer

Era of hope for patients with lung cancer

by Alex OsiadaczCredit: Pixabay/CC0 Public DomainNovember is Lung Cancer Awareness month. Lung cancer is the most common cancer worldwide, with more than 2.1 million cases, according to the American L

Era of hope for patients with lung cancer

by Alex OsiadaczCredit: Pixabay/CC0 Public DomainNovember is Lung Cancer Awareness month. Lung cancer is the most common cancer worldwide, with more than 2.1 million cases, according to the American L